Advisory Committee on the Medical Uses of Isotopes: Meeting Notice, 74201 [E8-28843]

Download as PDF Federal Register / Vol. 73, No. 235 / Friday, December 5, 2008 / Notices Dates & Times: Thursday, January 22, 2009, 2008; 7:30 a.m.–9:30 p.m.; Friday, January 23, 2009; 7:30 a.m.–4:30 p.m. Place: Brown University, Providence, RI. Type of Meeting: Part-open. Contact Person: Dr. Thomas Rieker, Program Director, Materials Research Science and Engineering Centers Program, Division of Materials Research, Room 1065, National Science Foundation, 4201 Wilson Boulevard, Arlington, VA 22230, Telephone (703) 292–4914. Purpose of Meeting: To provide advice and recommendations concerning further support of the MRSEC at Brown University, Providence, RI. Agenda: Thursday, January 22, 2009 7:45 a.m.–9 a.m.: Closed—Executive Session. 9 a.m.–4:30 p.m.: Open—Review of the Brown MRSEC. 4:30 p.m.–6 p.m.: Closed—Executive Session. 6 p.m.–9 p.m.: Open—Poster Session and Dinner. Friday January 23, 2009 8 a.m.–9 a.m.: Closed—Executive session. 9 a.m.–10:15 a.m.: Open—Review of the Brown MRSEC. 10:15 a.m.–3:30 p.m.: Closed— Executive Session, Draft and Review Report. Reason for Closing: The work being reviewed may include information of a proprietary or confidential nature, including technical information; financial data, such as salaries and personal information concerning individuals associated with the proposals. These matters are exempt under 5 U.S.C. 552 b(c), (4) and (6) of the Government in the Sunshine Act. December 2, 2008. Susanne Bolton, Committee Management Officer. [FR Doc. E8–28802 Filed 12–4–08; 8:45 am] BILLING CODE 7555–01–P NUCLEAR REGULATORY COMMISSION dwashington3 on PROD1PC60 with NOTICES Advisory Committee on the Medical Uses of Isotopes: Meeting Notice AGENCY: U.S. Nuclear Regulatory Commission. ACTION: Notice of meeting. SUMMARY: The U.S. Nuclear Regulatory Commission will convene a teleconference meeting of the Advisory Committee on the Medical Uses of VerDate Aug<31>2005 15:27 Dec 04, 2008 Jkt 217001 Isotopes (ACMUI) on December 18, 2008, to discuss infiltrations of fluorine18 and therapeutic radiopharmaceuticals as medical events; and the training and experience requirements for the medical use of NeoVista, Inc.’s Epi-Rad90 strontium-90 ophthalmic system. A copy of the agenda for the meeting will be available at http://www.nrc.gov/reading-rm/doccollections/acmui/agenda or by contacting Ms. Ashley Tull using the information below. NUCLEAR REGULATORY COMMISSION DATES: The teleconference meeting will be held on Thursday, December 18, 2008, from 1 p.m. to 3 p.m. Eastern Standard Time. Public Participation: Any member of the public who wishes to participate in the teleconference discussion should contact Ms. Tull using the contact information below. Contact Information: Ashley M. Tull, e-mail: ashley.tull@nrc.gov, telephone: (240) 888–7129. 74201 Tuesday, December 9, 2008 Conduct of the Meeting Leon S. Malmud, M.D., will chair the meeting. Dr. Malmud will conduct the meeting in a manner that will facilitate the orderly conduct of business. The following procedures apply to public participation in the meeting: 1. Persons who wish to provide a written statement should submit an electronic copy to Ms. Tull at the contact information listed above. All submittals must be received by December 15, 2008, and must pertain to the topic on the agenda for the meeting. 2. Questions and comments from members of the public will be permitted during the meeting, at the discretion of the Chairman. 3. The transcript will be available on the ACMUI’s Web site (http:// www.nrc.gov/reading-rm/doccollections/acmui/tr/) on or about January 21, 2009. A meeting summary will be available on or about February 3, 2009. This meeting will be held in accordance with the Atomic Energy Act of 1954, as amended (primarily Section 161a); the Federal Advisory Committee Act (5 U.S.C. App); and the Commission’s regulations in Title 10, U.S. Code of Federal Regulations, Part 7. Dated: December 1, 2008. Andrew L. Bates, Advisory Committee Management Officer. [FR Doc. E8–28843 Filed 12–4–08; 8:45 am] BILLING CODE 7590–01–P PO 00000 Frm 00072 Fmt 4703 Sfmt 4703 Sunshine Act; Notice of Meeting DATES: Week of December 8, 2008. PLACE: Commissioners’ Conference Room, 11555 Rockville Pike, Rockville, Maryland. STATUS: Public and closed. ADDITIONAL ITEMS TO BE CONSIDERED: Week of December 8, 2008 9:25 a.m. Affirmation Session (Public Meeting) (Tentative). b. Entergy Nuclear Operations, Inc. (Indian Point Nuclear Generating Units 2 and 3), re Appeal of Order Striking WestCAN’s Request for Hearing (July 31, 2008) (Tentative). This meeting will be Webcast live at the Web address— http://www.nrc.gov. * * * * * * The schedule for Commission meetings is subject to change on short notice. To verify the status of meetings, call (recording)—(301) 415–1292. Contact person for more information: Michelle Schroll, (301) 415–1662. * * * * * The NRC Commission Meeting Schedule can be found on the Internet at: http://www.nrc.gov/about-nrc/policymaking/schedule.html. * * * * * The NRC provides reasonable accommodation to individuals with disabilities where appropriate. If you need a reasonable accommodation to participate in these public meetings, or need this meeting notice or the transcript or other information from the public meetings in another format (e.g. braille, large print), please notify the NRC’s Disability Program Coordinator, Rohn Brown, at 301–492–2279, TDD: 301–415–2100, or by e-mail at REB3@nrc.gov. Determinations on requests for reasonable accommodation will be made on a case-by-case basis. * * * * * This notice is distributed by mail to several hundred subscribers; if you no longer wish to receive it, or would like to be added to the distribution, please contact the Office of the Secretary, Washington, DC 20555 (301–415–1969). In addition, distribution of this meeting notice over the Internet system is available. If you are interested in receiving this Commission meeting schedule electronically, please send an electronic message to dkw@nrc.gov. E:\FR\FM\05DEN1.SGM 05DEN1

Agencies

[Federal Register Volume 73, Number 235 (Friday, December 5, 2008)]
[Notices]
[Page 74201]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-28843]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Meeting 
Notice

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission will convene a 
teleconference meeting of the Advisory Committee on the Medical Uses of 
Isotopes (ACMUI) on December 18, 2008, to discuss infiltrations of 
fluorine-18 and therapeutic radiopharmaceuticals as medical events; and 
the training and experience requirements for the medical use of 
NeoVista, Inc.'s Epi-Rad90 strontium-90 ophthalmic system. A 
copy of the agenda for the meeting will be available at http://
www.nrc.gov/reading-rm/doc-collections/acmui/agenda or by contacting 
Ms. Ashley Tull using the information below.

DATES: The teleconference meeting will be held on Thursday, December 
18, 2008, from 1 p.m. to 3 p.m. Eastern Standard Time.
    Public Participation: Any member of the public who wishes to 
participate in the teleconference discussion should contact Ms. Tull 
using the contact information below.
    Contact Information: Ashley M. Tull, e-mail: ashley.tull@nrc.gov, 
telephone: (240) 888-7129.

Conduct of the Meeting

    Leon S. Malmud, M.D., will chair the meeting. Dr. Malmud will 
conduct the meeting in a manner that will facilitate the orderly 
conduct of business. The following procedures apply to public 
participation in the meeting:
    1. Persons who wish to provide a written statement should submit an 
electronic copy to Ms. Tull at the contact information listed above. 
All submittals must be received by December 15, 2008, and must pertain 
to the topic on the agenda for the meeting.
    2. Questions and comments from members of the public will be 
permitted during the meeting, at the discretion of the Chairman.
    3. The transcript will be available on the ACMUI's Web site (http:/
/www.nrc.gov/reading-rm/doc-collections/acmui/tr/) on or about January 
21, 2009. A meeting summary will be available on or about February 3, 
2009.
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in Title 
10, U.S. Code of Federal Regulations, Part 7.

    Dated: December 1, 2008.
Andrew L. Bates,
Advisory Committee Management Officer.
 [FR Doc. E8-28843 Filed 12-4-08; 8:45 am]
BILLING CODE 7590-01-P